Mold-Tek Packaging Q2 FY27 PAT Up 36.06% to ₹21.09 Crore on 30.73% Sales Growth
Mold-Tek Packaging reported Q2 FY27 Net Profit up 36.06% to ₹21.09 crore and Revenue up 30.73% to ₹274.23 crore. Sales volume rose 10.08% driven by Pharma and FMCG segments. H1 FY27 Net Profit grew 23.18% to ₹46.67 crore. New products like IODEX containers and eye dropper packs are expected to contribute from Q3/Q4 FY27.
Significant growth in key financial metrics like profit and revenue, coupled with positive outlook and new product developments, indicates a high impact on investor sentiment and company valuation.
The company reported strong year-on-year growth in net profit, revenue, and sales volume, with positive commentary on future prospects and segment performance.
Mold-Tek Packaging Limited announced its financial results for the quarter and half-year ended September 30, 2026. The company reported a Net Profit of ₹21.09 crore for Q2 FY2027, marking a significant increase of 36.06% compared to the same period last year. Revenue from operations grew by 30.73% to ₹274.23 crore, while EBITDA increased by 29.80% to ₹51.27 crore.
Sales volume saw a rise of 10.08% to 11,028.46 MT, driven by strong performance in the Pharma Packaging (26.30% volume growth) and Food & FMCG Packaging (23.70% volume growth) segments. Paints Packaging also showed steady growth (8.61%), while Lubricants Packaging experienced a decline. The company highlighted its ability to pass on raw material cost increases to customers, protecting operating margins, and noted an improved EBITDA per kg of ₹46.49.
For the half-year ended September 30, 2027 (H1 FY2027), Net Profit increased by 23.18% to ₹46.67 crore, with Revenue from Operations growing by 27.62% to ₹574.67 crore and EBITDA by 23.97% to ₹107.70 crore. Sales volume for H1 FY2027 increased by 8.04% to 23,116.98 MT.
The company anticipates future growth from new product developments, including IODEX containers starting Q3 FY27, and other new packs expected to add revenues from Q4 FY27. Eye dropper pack moulds are expected to be ready by Q4 FY27 for commercial production in Q1 FY28. Mold-Tek is also exploring opportunities in Trays, Dosing Pens, and Semi-conductors packaging. New orders have been secured from companies like Kannan Fiber Industries, Mittal Polymers Private Limited, Avakaaya Foods, Pharmaforce, and Life wise Pharmaceuticals.
What to do with a filing like this
Mold-Tek Packaging Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Mold-Tek Packaging Limited. Read the original for the full detail.